| Lastest Insider Transactions Of Lineage Cell Therapeutics, Inc. ( LCTX ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | President and CEO | 2026-02-11 | Option Exercise | 31,250 | 0.00 | 0 | 2026-02-13 19:30:06 |
| LCTX | Lineage Cell Therapeutics, Inc. | Samuel George A. III | General Counsel and Secretary | 2026-02-11 | Option Exercise | 6,075 | 0.00 | 0 | 2026-02-13 19:30:03 |
| LCTX | Lineage Cell Therapeutics, Inc. | Samuel George A. III | General Counsel | 2025-02-11 | Option Exercise | 6,076 | 0.00 | 0 | 2025-02-12 16:30:08 |
| LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | President and CEO | 2025-02-11 | Option Exercise | 31,249 | 0.00 | 0 | 2025-02-12 16:30:06 |
| LCTX | Lineage Cell Therapeutics, Inc. | BROADWOOD PARTNERS, L.P. | Directior 10% Owner | 2025-01-27 | Buy | 7,894,737 | 0.76 | 6,000,000 | 2025-01-28 19:49:41 |
| LCTX | Lineage Cell Therapeutics, Inc. | Howe Jill Ann | Chief Financial Officer | 2024-11-26 | Buy | 15,000 | 0.59 | 8,850 | 2024-11-26 16:58:31 |
| LCTX | Lineage Cell Therapeutics, Inc. | Samuel George A. III | General Counsel | 2024-11-26 | Buy | 15,000 | 0.60 | 9,000 | 2024-11-26 16:55:46 |
| LCTX | Lineage Cell Therapeutics, Inc. | Mulroy Michael H. | Directior | 2024-11-22 | Buy | 40,000 | 0.57 | 22,640 | 2024-11-25 16:30:03 |
| LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | President and CEO | 2024-11-21 | Buy | 40,000 | 0.60 | 24,000 | 2024-11-22 09:00:04 |
| LCTX | Lineage Cell Therapeutics, Inc. | Howe Jill Ann | Chief Financial Officer | 2024-08-16 | Buy | 10,500 | 0.89 | 9,345 | 2024-08-19 18:24:46 |
| LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | President and CEO | 2024-05-24 | Buy | 10,000 | 1.05 | 10,500 | 2024-05-28 09:11:23 |
| LCTX | Lineage Cell Therapeutics, Inc. | Samuel George A. III | General Counsel/Secretary | 2024-02-11 | Option Exercise | 6,076 | 0.00 | 0 | 2024-02-12 21:30:12 |
| LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | President and CEO | 2024-02-11 | Option Exercise | 31,249 | 0.00 | 0 | 2024-02-12 21:27:33 |
| LCTX | Lineage Cell Therapeutics, Inc. | BAILEY DON M | Directior | 2024-02-08 | Buy | 96,155 | 1.04 | 100,001 | 2024-02-08 19:00:09 |
| LCTX | Lineage Cell Therapeutics, Inc. | BAILEY DON M | Directior | 2024-02-08 | Buy | 96,155 | 1.04 | 100,001 | 2024-02-08 19:00:09 |
| LCTX | Lineage Cell Therapeutics, Inc. | BROADWOOD PARTNERS, L.P. | Directior 10% Owner | 2024-02-06 | Buy | 6,730,770 | 1.04 | 7,000,001 | 2024-02-08 18:58:18 |
| LCTX | Lineage Cell Therapeutics, Inc. | Jayasuriya Anula | Directior | 2023-12-29 | Buy | 10,000 | 1.09 | 10,900 | 2024-01-02 19:08:49 |
| LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | President and CEO | 2023-02-11 | Option Exercise | 31,249 | 0.00 | 0 | 2023-02-14 16:15:52 |
| LCTX | Lineage Cell Therapeutics, Inc. | Samuel George A. III | General Counsel/Secretary | 2023-02-11 | Option Exercise | 6,076 | 0.00 | 0 | 2023-02-14 16:15:47 |
| LCTX | Lineage Cell Therapeutics, Inc. | Hogge Gary S. | SVP,Clinical & Medical Affairs | 2023-02-11 | Option Exercise | 13,020 | 0.00 | 0 | 2023-02-14 16:15:41 |
